The global narcolepsy drugs market reached a value of nearly USD 3.63 Billion in 2023 and is further projected to achieve USD 8.84 Billion by 2032, recording a CAGR of 10.40% over the forecast period of 2024-2032.
Base Year
Historical Year
Forecast Year
Value in USD Billion
2024-2032
Narcolepsy Drugs Market Outlook
*this image is indicative*
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The industry is being driven by the rapidly advancing technology, increased investment in the R&D sector by leading pharmaceutical companies, and the rising awareness regarding narcolepsy and its treatment among people.
Narcolepsy refers to a sleep disorder that causes excessive daytime drowsiness and is characterised by sleep paralysis and hallucinations, among other factors. It is a neurological disorder involving a reduced capacity to control sleep and wake cycles. The global narcolepsy drugs market can be segmented into disease type and therapeutic type. Market Breakup by Drug Class: Market Breakup by Disease Type: Market Breakup by Dosage Form: Market Breakup by Route of Administration: Market Breakup by Population Type:
Market Breakup by End User:
Market Breakup by Treatment Channel:
Market Breakup by Distribution Channel:
Market Breakup by Region:
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The increased prevalence of narcolepsy, awareness regarding sleep disorders due to narcolepsy awareness programmes and camps, and the growing presence of reimbursement policies are the major factors that are accelerating the growth of the global narcolepsy drugs market. Further, the rising disposable incomes and increased expenditure in the health care sector by the governments, particularly in the developing nations, is expected to aid the global narcolepsy drugs market over the forecast period. The adverse effects related to narcolepsy drugs, along with the chances of delayed diagnosis or misdiagnosis, are the major drawbacks, which may affect the industry growth in the forecast period.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The report presents a detailed analysis of the following key players in the global narcolepsy drugs market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
In 2020, the global narcolepsy drugs market attained a value of about USD 3.63 Billion in 2023.
The market is projected to grow at a CAGR of 10.40% between 2024 and 2032.
The market is being driven by the rising awareness regarding narcolepsy and its treatment methods, technological advancements, and the increasing research and development (R&D) activities.
The market growth is anticipated to be defined by the rising disposable incomes, the increasing expenditure in the healthcare sector, and the introduction of favourable governmental initiatives to enhance the accessibility of narcolepsy drugs.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The major disease types of narcolepsy drugs include daytime extreme sleepiness and cataplexia, among others.
The significant therapeutic types of narcolepsy drugs are central nervous system stimulants, tricyclic antidepressants, sodium oxybate, and selective serotonin reuptake inhibitor, among others.
The major players in the industry are Arena Pharmaceutical, Inc., Jazz Pharmaceutical Plc, Bioprojet Pharma Sarl, Ligand Pharmaceuticals Incorporated, Shinogi Inc., Takeda Pharmaceutical Company, and Teva Pharmaceutical Industries Ltd., among others.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Drug Class |
|
| Breakup by Disease Type |
|
| Breakup by Dosage Form |
|
| Breakup by Route of Administration |
|
| Breakup by Population Type |
|
| Breakup by End User |
|
| Breakup by Treatment Channel |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share